The answer depends on your priorities. If you value published scientific evidence, zero-damage technology, and the production of natural (not scar tissue) collagen, LYMA Laser offers a clinically-proven alternative. The 45-gene activation profile and SIRT1 longevity pathway engagement have no equivalent in microneedling research.

Yes, with peer-reviewed evidence to prove it. The 2025 study published in Aesthetic Surgery Journal Open Forum demonstrated 45 genes modulated in human dermal tissue, including 32× upregulation of antioxidant defence (TXNRD1), 31× tissue regeneration (HBEGF), and 6× longevity gene activation (SIRT1). A randomised controlled trial showed 78% wound healing improvement.

Some people incorporate both into their routine. However, LYMA Laser should not be used immediately after microneedling while skin is still healing. Allow skin to fully recover (typically 5-7 days) before resuming LYMA Laser use. Given LYMA's zero-damage approach, many users find they no longer need microneedling once they experience the laser's results.

Most users report visible improvements within 30 days of daily use. The gene expression changes begin immediately, but cellular turnover means visible skin changes take time to manifest. Consistent daily use delivers cumulative benefits.

In the same clinical study, LYMA Laser activated 45 genes while a comparable LED device (810nm, actually 10× higher power than LYMA) activated just 1 gene. The difference comes down to light physics: laser light is coherent and collimated, delivering energy efficiently to cells. LED light is diffuse and scattered, with much energy lost before reaching target tissue.